Annual report pursuant to Section 13 and 15(d)

Schedule of Valuation of Financial Instruments at Fair Value on a Recurring Basis (Details)

v3.22.1
Schedule of Valuation of Financial Instruments at Fair Value on a Recurring Basis (Details) - USD ($)
Dec. 31, 2021
Dec. 31, 2020
Defined Benefit Plan Disclosure [Line Items]    
Right-of-use-asset $ 195,029
Convertible notes payable, debt discounts 412,673  
Fair Value, Inputs, Level 1 [Member]    
Defined Benefit Plan Disclosure [Line Items]    
Cash 119,678 28,920
Right-of-use-asset  
Total assets 119,678 28,920
Convertible notes payable, net of $412,673 of debt discounts  
Convertible notes payable  
Lease liabilities  
Notes payable  
Total liabilities
Total assets and liabilities 119,678 28,920
Fair Value, Inputs, Level 2 [Member]    
Defined Benefit Plan Disclosure [Line Items]    
Cash
Right-of-use-asset  
Total assets
Convertible notes payable, net of $412,673 of debt discounts 337,327  
Convertible notes payable 319,274  
Lease liabilities  
Notes payable   334,841
Total liabilities (656,601) (334,841)
Total assets and liabilities (656,601) (334,841)
Fair Value, Inputs, Level 3 [Member]    
Defined Benefit Plan Disclosure [Line Items]    
Cash
Right-of-use-asset   195,029
Total assets 195,029
Convertible notes payable, net of $412,673 of debt discounts  
Convertible notes payable  
Lease liabilities   201,525
Notes payable  
Total liabilities (201,525)
Total assets and liabilities $ (6,496)